Table 1.
Characteristics of patients with CD
| Characteristics | N a (Percentage) |
|---|---|
| Age (18–40, ≥40) | |
| 18–37 | 10 (40%) |
| 38–57 | 15 (60%) |
| Gender | |
| M | 16 (64%) |
| F | 9 (36%) |
| Location (ileal, colonic, ileocolic, upper intestine) | |
| Duodenum/jejunum | 2 (8%) |
| Ileum/ileostomy | 12 (48%) |
| Right/transverse colon | 3 (12%) |
| Left colon | 2 (8%) |
| Rectum | 4 (16%) |
| Mixed | 2 (8%) |
| Medications | |
| 5-aminosalicylic acid, 5-ASA alone | 1 |
| Budesonide alone | 1 |
| Prednisone alone | 1 |
| Immunomodulators (imm) | 2 |
| Imm + prednisone | 1 |
| Biologics (all anti-TNF except one integrin) | 8 |
| Biologic + 5-ASA | 1 |
| Biologic + budesonide | 1 |
| Biologic + steroids | 2 |
| Biologic + imm + budesonide | 1 |
| Biologic + imm + steroids | 1 |
| Biologic + imm + steroids + 5-ASA | 1 |
| Untreated | 4 |
aAll patients included in this study had active disease, tissue inflammation was scored as moderate/severe.